Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Aspirin study

This article was originally published in The Tan Sheet

Executive Summary

Aspirin study: One-third of elderly heart attack patients do not receive aspirin within two days after hospitalization, "although aspirin is an effective, inexpensive, and safe treatment of acute myocardial infarction," according to a study published in the Nov. 15 issue of the American Heart Association journal, Circulation. "After adjustment for differences between the treatment groups, the use of aspirin was associated with 22% lower odds of 30-day mortality," Harlan Krumholz, MD, et al. found. The researchers looked at about 10,000 patient medical records from four states...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084504

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel